(firstQuint)A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs.

 Patients are randomized to receive open-label emtricitabine or ABC in combination with stavudine and efavirenz.

 Viral load and CD4+ cell counts are compared at Weeks 24 and 48.

 Patients are followed for 48 weeks.

.

 A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs@highlight

This study will look at whether emtricitabine is as safe and effective as abacavir (ABC) when taken with stavudine (d4T) and efavirenz (EFV) in patients who have never taken anti-HIV drugs.

